SCHEMBL8636729

SCHEMBL8636729

Cc1cc(-c2cc(C(F)(F)F)nn2NS(=O)(=O)c2ccccc2)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.43
PTGS1 P23219 8/20 0.42
PDPK1 O15530 2/20 0.39
RXRA P19793 1/20 0.38
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8641600 0.91 PTGS2 (0.44) PTGS2PTGS1PDPK1RXRANR1H2
SCHEMBL8688451 0.88 PTGS2 (0.42) PTGS2PTGS1PDPK1CYP2C9TSHR
SCHEMBL8637083 0.88 RXRA (0.44) PTGS2PTGS1PDPK1RXRANR1H2
SCHEMBL8688899 0.87 PTGS2 (0.44) PTGS2PTGS1PDPK1RXRANR1H2
SCHEMBL8688673 0.87 PTGS2 (0.43) PTGS2PTGS1PDPK1RXRANR1H2
SCHEMBL7135445 0.86 PTGS2 (0.51) PTGS2PTGS1PDPK1CYP2C9TSHR
SCHEMBL8639246 0.86 PTGS2 (0.56) PTGS2PTGS1
SCHEMBL8693368 0.86 PTGS2 (0.44) PTGS2PTGS1PDPK1RXRANR1H2
SCHEMBL8688820 0.86 PTGS2 (0.56) PTGS2PTGS1PDPK1RXRANR1H2
SCHEMBL8692172 0.86 RXRA (0.44) PTGS2PTGS1PDPK1RXRANR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760068-A NONSTEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G.D. SEARLE & CO. (US) 1998-06-02 US disclosed
US-5756529-A ANTIINFLAMMATORY G.D. SEARLE & CO. (US) 1998-05-26 US disclosed
US-5753688-A ANTIINFLAMMATORY TALLEY JOHN J (US) 1998-05-19 US disclosed
US-5510496-A ANTIINFLAMMATORY AGENTS G.D. SEARLE & CO. (US) 1996-04-23 US disclosed
US-5504215-A Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-04-02 US disclosed